Open Access Open Badges Research article

The SNP at −592 of human IL-10 gene is associated with serum IL-10 levels and increased risk for human papillomavirus cervical lesion development

Kirvis Torres-Poveda1, Ana I Burguete-García1, Miguel Cruz2, Gabriela A Martínez-Nava1, Margarita Bahena-Román1, Esmeralda Ortíz-Flores1, Abrahan Ramírez-González1, Guillermina López-Estrada3, Karina Delgado-Romero4 and Vicente Madrid-Marina1*

Author Affiliations

1 Dirección de Infecciones Crónicas y Cáncer. Centro de Investigación sobre Enfermedades Infecciosas (CISEI), Instituto Nacional de Salud Pública, Av. Universidad 655, Santa María Ahuacatitlán, Cuernavaca, C.P.62100, Cuernavaca, México

2 Unidad de Investigación Médica en Bioquímica, Hospital de Especialidades, Centro Médico Siglo XXI, IMSS, Mexico, DF, Mexico

3 Private Health Center for Gynecology, Cuernavaca, Morelos, Mexico

4 Centro de Atención para la Salud de la Mujer (CAPASAM). (Center for Women’s Health), Health Services of the State of Morelos, Cuernavaca, Mexico

For all author emails, please log on.

Infectious Agents and Cancer 2012, 7:32  doi:10.1186/1750-9378-7-32

Published: 14 November 2012



Women with Human Papilloma Virus (HPV) persistence are characterized by high levels of IL-10 at cervix. We have determined whether polymorphisms of IL-10 gene promoter might be associated with increased risk of squamous intraepithelial cervical lesions (SICL) and whether exist significative differences of IL-10 mRNA expression at cervix and systemic and serum IL-10 protein between SICL cases and non-Cervical Lesions (NCL).


Peripheral blood samples from SICL (n = 204) and NCL (n = 166) were used to detect IL-10 promoter polymorphisms at loci -592A/C (rs1800872), -819C/T (rs1800871), -1082A/G (rs1800896), -1352A/G (rs1800893), by allelic discrimination and to evaluate serum IL-10 protein. Cervical epithelial scrapings from NCL and biopsies from SICLs were used for HPV-typing and to evaluate IL-10 mRNA expression level. The systemic and local IL-10 mRNA expression levels were measured by real time-PCR. Genotypic and allelic frequencies of the selected polymorphisms were analyzed by logistic regression, adjusting by age and HPV-genotype, to determine the association with SICL.


No significant differences were found between genotype frequencies at loci −819, -1082, and −1352. Individuals carrying at least one copy of risk allele A of polymorphism −592 had a two-fold increased risk of developing SICL [adjusted odds ratio (OR), 2.02 (95% CI, 1.26-3.25), p = 0.003], compared to NCL. The IL-10 mRNA expression and serum IL-10 protein, were significantly higher in SICL cases (p < 0.01), being higher in patients carrying the risk allele A.


The −592 polymorphism is associated with increased risk of SICL and can serve as a marker of genetic susceptibility to SICL among Mexican women. According to IL-10 levels found in SICL, IL-10 can be relevant factor for viral persistence and progression disease.

IL-10 promoter polymorphisms; Squamous intraepithelial cervical lesions; IL-10 expression; Risk factors